Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (741-750 of 1,123) with videos related to

Pageof 113
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]M Burger, J Catto, J van Oers, et al.
International Journal of Cancer|January 19, 2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjectsEsther M Hollander, Alessandra I G Buma, Jenneke Leentjens, et al.
HIV Medicine|March 19, 2024
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and UgandaTom G Jacobs, Dorothy Okemo, Anthony Ssebagereka, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2007
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practiceR M M Cleijsen, M E van de Ende, F P Kroon, et al.
European Journal of Clinical Pharmacology|July 29, 2018
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newbornsRobert B Flint, Rob Ter Heine, Edwin Spaans, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
HIV Medicine|December 2, 2017
Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfectE J Smolders, C Smit, Ctmm de Kanter, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
International Journal of Cardiology|March 12, 2023
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular diseasePascal M Burger, Stefan Koudstaal, Jannick A N Dorresteijn, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2024
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-ITPascal M Burger, Deepak L Bhatt, Jannick A N Dorresteijn, et al.
Pageof 113

Showing results (741-750 of 1,123) with videos related to

Sort By:
Pageof 113
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|September 18, 2007
[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract]M Burger, J Catto, J van Oers, et al.
International Journal of Cancer|January 19, 2026
No relevant pharmacokinetic interaction between the KRAS G12C inhibitor sotorasib and the direct oral anticoagulant rivaroxaban in healthy subjectsEsther M Hollander, Alessandra I G Buma, Jenneke Leentjens, et al.
HIV Medicine|March 19, 2024
Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and UgandaTom G Jacobs, Dorothy Okemo, Anthony Ssebagereka, et al.
The Journal of Antimicrobial Chemotherapy|August 21, 2007
Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practiceR M M Cleijsen, M E van de Ende, F P Kroon, et al.
European Journal of Clinical Pharmacology|July 29, 2018
Simulation-based suggestions to improve ibuprofen dosing for patent ductus arteriosus in preterm newbornsRobert B Flint, Rob Ter Heine, Edwin Spaans, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
HIV Medicine|December 2, 2017
Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfectE J Smolders, C Smit, Ctmm de Kanter, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
International Journal of Cardiology|March 12, 2023
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular diseasePascal M Burger, Stefan Koudstaal, Jannick A N Dorresteijn, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 27, 2024
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-ITPascal M Burger, Deepak L Bhatt, Jannick A N Dorresteijn, et al.
Pageof 113